Table 2 Number of individuals with each symptom and no symptoms at 3 months, 6 months and long term follow-up (6 years) by randomisation group.
From: Long term follow-up of a randomised controlled trial of services for urinary symptoms
| Â | Â | Intervention | Standard care | Difference (95% Cl; P value) | ||
|---|---|---|---|---|---|---|
| Â | Â | Total responders | Individuals with symptoms/event (%) | Total responders | Individuals with symptoms/event (%) | Â |
Improvement | 3-months | 2378 | 1417 (60%) | 584 | 281 (48%) | 11% (7 to 16; P = < 0.001) |
| Â | 6 months | 2201 | 1369 (62%) | 536 | 277 (52%) | 11% (6 to 15 P < 0.001) |
| Â | Long term follow-up | 2045 | 1530(72%) | 567 | 380 (67%) | 5% (0.6 to 9; P = 0.02) |
No symptoms (cure) | 3-months | 2378 | 591 (25%) | 584 | 88 (15%) | 10% (6% to 13%; p < 0.001) |
| Â | 6 months | 2201 | 624 (28%) | 536 | 104 (19%) | 9% (5% to 13%; p < 0.001) |
| Â | Long term follow-up | 2069 | 643 (31%) | 571 | 156 (27%) | 4% (-0.4 to 8; P = 0.08) |
Leakage (several times per month or more) | Baseline | 2958 | 2392 (82%) | 788 | 618 (79%) | Â |
| Â | 3 months | 2483 | 1567 (63%) | 612 | 428 (70%) | -7% (-11% to -3%; p = 0.002) |
| Â | 6 months | 2235 | 1362 (61%) | 546 | 356 (65%) | -4% (-9% to 0%; p = 0.066) |
| Â | Long term follow-up | 2093 | 1166 (56%) | 580 | 334 (58%) | -2% (-6 to 3; P = 0.4) |
Frequency (hourly or more) | Baseline | Â | 1563 (53%) | Â | 376 (48%) | Â |
| Â | 3 months | 2428 | 723 (30%) | 598 | 219 (37%) | -7% (-11% to -2%; p = 0.001) |
| Â | 6 months | 2231 | 539 (24%) | 545 | 182 (33%) | -9% (-14% to -5%; p < 0.001) |
| Â | Long term follow-up | 2098 | 290 (14%) | 576 | 85 (15%) | -1% (-4 to 2; P = 0.6) |
Urgency (very strong or overwhelming) | Baseline | Â | 1927 (65%) | Â | 529 (67%) | Â |
| Â | 3 months | 2503 | 819 (33%) | 618 | 248 (40%) | -7% (-12% to -3%; p = 0.001) |
| Â | 6 months | 2236 | 682 (31%) | 546 | 228 (42%) | -11% (-16% to -7%; p < 0.001) |
| Â | Long term follow-up | 2108 | 482 (23%) | 583 | 153 (26%) | -3% (-7% to 0.6%;p = 0.09) |
Nocturia (3 times per night or more) | Baseline | Â | 1070 (36%) | Â | 285 (36%) | Â |
| Â | 3 months | 2502 | 497 (20%) | 617 | 164 (27%) | -7% (-11% to -3%; p < 0.001) |
| Â | 6 months | 2236 | 420 (19%) | 547 | 133 (24%) | -6% (-9% to -2%; p = 0.004) |
| Â | Long term follow-up | 2106 | 437 (21%) | 585 | 135 (23%) | -2% (-6 to 2; P = 0.2) |